Skip to main content

Table 3 Response to hormonal therapy

From: The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozole

Treatment

PR (%)

SD (%)

PD (%)

ORR (%)

CBR (%)

CA125 response (%)

Tamoxifen (n = 43)

6 (14)

22 (51.2)

15 (34.9)

6 (14)

28 (65.1)

10 (23.3)

Letrozole (n = 54)

8 (14.8)

22 (40.7)

24 (44.4)

8 (14.8)

30 (55.6)

12 (22.2)

Total (n = 97)

14 (14.4)

44 (45.4)

39 (40.2)

14 (14.4)

58 (59.8)

22 (22.7)

  1. Abbreviations: CBR clinical benefit rate, ORR objective response rate, PD progressive disease, PR partial response, SD stable disease